Descending trinagle. Support 118. Reistance 150. Big area to chop. Upside target if break 150 and close above we would target 209. If we break and hold below 118 as reistance then we would target 47/50$. This could be a nice pickup closer to the 118 zone of support. Buyers are holding that level as of now. Buying any dip unless 118 is broken and starting to close below
BNTX looks to be completing a primary B wave retracement to begin the bio bear market. Target $167. Not advice.
BNTX Price finds support at monthly pivot S1 line and daily inside bar has been formed. Close above 150.3$ triggers idea with profit target 187$ and stop 145$. Risk Reward ratio 7.0
Angry bear has mad a weapon integrating three powerful and heavy elements and waiting for the stock to hammer it down ! Long term down trend line , 200 days moving average and lost golden ratio Retracement level are the elements of the bear's weapon. Can BNTX make a heroic attack and defeat the angry bear? Not without a powerful comparable weapon I think. It...
BNTX will pop-up on next earnings day. Technicals suggest the stock has been building a bottom the last couple of months. Now is well above the 50 day EMA and it is begining to challenge the 200 day EMA. The P/E ratio and Forward P/E ratio are in the low single digits. I expanded my position when BNTX crossed above the 50 day EMA.
Buy Above $ 170 TGT- 180 TGT-2- 186 SL 159 Sell Below 159 TGT- 153 TGT-2 149 SL 165
BNTX is finally concluding a year long descending triangle pattern. I see a low risk entry at $150 and will be buying. Stop loss set at $138.49, risking about 8.5%. If we see a large move upward, I could see the stock retesting both its 200 day moving average (likely at $183) and its next major resistance after that at $295. A potential of nearly 100% profit (not...
$BNTX Breakout in 1h Chart 1. Positive Super Trend in 4h Chart & Consolidation > 8 days 2. Several touching points with vwap 3. Price above 10, 20 & 50 EMA 4. Target 205$ 5. Stop-Loss 164$ 6. Risk Reward Ratio 11.3
The PEAD projected a Bullish outlook for $BNTX after a Positive Under reaction following its earnings release placing the stock in drift A.
The Statistics say between $182-$253 (1 year) This Looks like it can Happen in 1 Year. That will depend on their Progress. Let's see what will happen in 2023, but it looks ok to hold for the next 5 Years or more BioNTech aims to develop the first mRNA-based vaccine for Malaria prevention with the initiation of a clinical trial by end of 2022 BioNTech is...
Entering here for a possible inv h&s continuation targeting 240. (1.618 fib level). Stop loss @120. Should be a good spot to take profits and leave half running.
$bntx has NO volume support until green box 24% lower... #bntx —————————————————————————————— Top 10 trading tips: 1. DO NOT FOMO into a trade. Let it come to you. Don’t force it. 2. Find a strategy that works for you and be consistent. Operate like a machine and less like the wind. 3. Let your winners run and cut your losers short. 4. You will not win every...
Swing Idea For 4/7 under 159 145-148 possible #options #optionstrading
BioNTech Q4 December 21' earnings are on 3/30 pre-market 6:45am. BioNTech Se ADR (BNTX) reported Q3 September 2021 earnings of $14.56 per share on revenue of $7.2 billion. The consensus earnings estimate was $11.79 per share on revenue of $5.8 billion. Revenue grew 9,003.0% on a year-over-year basis. I'm long now because a P/E = 3.7 for a leading MRNA...
chart-art shows POSSIBLE uptrend , green trend-line means bullish . Over the ma line can_be 🐂, & under will be bearish Short to midterm . ~~N0 arrows. ~~ N0T trading Advise either +dyor pls
If the vaccine and booster shots don't start working soon, and they can prove that it is really effective we might possibly see this share price go to ZERO. On a personal level, if that happens we might see the virus infections dissapear completely. Always consider what the price can possibly do. This is for educational purposes and should not seen as trading advice.
News - Better than expected Q4 EPS and sales results, the company expects to authorize a shares repurchase program up to 1.5B over the next two years. Levels -$195 is the next major resistance level. $138 is the next major support level. The stock is gapping up to $183 (pre-market). The idea is to go long at the open when it will try to test the $183 support...